Category: Pakistan

ALLR FINAL DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important November 12 Deadline in Securities Class Action – ALLR

NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Allarity Therapeutics, Inc. (NASDAQ: ALLR) between May 17, 2022 and July 19, 2024, both dates inclusive (the “Class Period”), of the important November 12, 2024 lead plaintiff deadline. SO WHAT: If you purchased Allarity securities […]

ROSEN, SKILLED INVESTOR COUNSEL, Encourages AMMO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – POWW

NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AMMO, Inc. (NASDAQ: POWW) between August 19, 2020 and September 24, 2024, both dates inclusive (the “Class Period”), of the important November 29, 2024 lead plaintiff deadline. SO WHAT: If you purchased AMMO securities during […]

COIN DEADLINE ALERT: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Coinbase Global, Inc. Investors to Secure Counsel Before Important November 12 Deadline in Securities Class Action First Filed by the Firm – COIN

NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Coinbase Global, Inc. (NASDAQ: COIN) between April 14, 2021 and July 25, 2024, both dates inclusive (the “Class Period”), of the important November 12, 2024 lead plaintiff deadline in the securities class action first filed […]

Nyxoah Appoints John Landry as Chief Financial Officer

Nyxoah Appoints John Landry as Chief Financial Officer Current CFO, Loïc Moreau, to Transition into Role of President International Mont-Saint-Guibert, Belgium – November 4, 2024, 10:45pm CET / 4:45pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today […]